In the future, a simple blood test could identify who will develop pre-eclampsia
Read now →Pre-eclampsia is the second leading cause of maternal mortality, and symptoms don't manifest until late in a pregnancy
Emily LaPlante
Computational Genomics
Baylor College of Medicine
I’m a PhD student at Baylor College of Medicine and I work in Computational Genomics. What happens after data is gathered? It has to be analyzed! That’s my specialty for data relating to pancreatic cancer and liquid biopsy. Have you ever wanted to know if you’ve got cancer by a spitting in a tube or a heart condition by drawing blood rather than invasive and painful tests? That’s the world of liquid biopsy where I process and study data related to over 15 conditions. Concerned with the fact that pancreatic cancer is the 3rd leading cause of cancer death while accounting for 3% of cases? Welcome to the world of genomics where I analyze genetic sequencing of patients and relate it to therapy response to see if we can predict or create new treatments for this deadly disease.
Pre-eclampsia is the second leading cause of maternal mortality, and symptoms don't manifest until late in a pregnancy
This new subtyping method will head to clinical trials